June NCI Office of Advocacy Relations Update

National Cancer Institute sent this bulletin at 06/03/2019 02:33 PM EDT
National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

 

 

You are subscribed to the Office of Advocacy Relations Update from the National Cancer Institute. Read highlights of the latest news and upcoming events happening at NCI. 

 

Upcoming Events

Joint Board of Scientific Advisors (BSA) / National Cancer Advisory Board (NCAB) Meeting, June 9-10, 2019

 

Frederick National Laboratory Advisory Committee (FNLAC) Meeting, June 27, 2019

 

Clinical Trials & Translational Research Advisory Committee (CTAC) Meeting, July 17, 2019

 

Note: Videocasts for advisory board meetings will be available at https://videocast.nih.gov/ the day of the meeting and will be archived shortly after for viewing on demand.

Recent NCI Announcements

  
Annual Report to the Nation on the Status of Cancer (May 30, 2019) 

The latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decline in men, women, and children in the United States from 1999 to 2016. Overall cancer incidence rates, or rates of new cancers, decreased in men from 2008 to 2015, after increasing from 1999 to 2008, and were stable in women from 1999 to 2015. In a special section of the report, researchers looked at cancer rates and trends in adults ages 20 to 49.

 

Study shows incidence rates of aggressive subtypes of uterine cancer rising (May 22, 2019)

New findings from a study by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, show that U.S. incidence rates for aggressive subtypes of uterine cancer rose rapidly among women ages 30 to 79 from 2000 to 2015.

Recent Cancer Currents Posts

  

Studying Genes and Proteins Together Sheds New Light on Colon Cancer (May 28, 2019)

Using novel proteogenomic techniques, scientists from NCI’s Clinical Proteomic Tumor Analysis Consortium have uncovered new features of colon cancer that may guide new treatment strategies.

 

Pediatric MATCH Study Finds More Targetable Genetic Changes than Expected (May 16, 2019)

An early report from the NCI–COG Pediatric MATCH trial shows that 24% of young patients with advanced cancer who had their tumors tested for genetic changes were eligible to receive one of the targeted therapies being tested.

 

Prostate Cancer Prevention and Finasteride: A Conversation with NCI’s Dr. Howard Parnes (May 13, 2019)

The Prostate Cancer Prevention Trial showed that finasteride can reduce the risk of prostate cancer, but might increase the risk of aggressive disease. NCI’s Howard Parnes talks about subsequent findings and what they mean for men aged 55 and older.

 

New Drugs, New Side Effects: Complications of Cancer Immunotherapy (May 10, 2019)   

The expanding use of cancer immunotherapy has revealed a variety of side effects associated with this treatment approach. Researchers are now trying to better understand how and why these side effects occur and develop strategies for better managing them.

 

Some Children with Liver Cancer May Need Less Chemotherapy, Study Suggests (May 9, 2019)           

Some children with liver cancer may need less chemotherapy than is typically used, new research suggests. The study included children and infants with hepatoblastoma whose tumors had been surgically removed when the disease was diagnosed.

 

Read more news at the Cancer Currents blog.